Replies to post #419760 on Amarin Corp Plc (AMRN)

[JRoon71]

I also just received a response to my follow-up e-mail to her, with a little more color (I asked her about the presentation at CTAD):

I presented preliminary results in addition to the overall trial design. The preliminary results suggest that the trial may not meet its primary endpoint, which was an improvement in blood flow in the brain. However, that may change with the final analyses.

Regards, Carol